BRIGHT HEALTH GROUP INC (BHG) Fundamental Analysis & Valuation

NYSE:BHG • US10920V4041

Current stock price

16.35 USD
+1.4 (+9.36%)
Last:

This BHG fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

0

1. BHG Profitability Analysis

1.1 Basic Checks

  • In the past year BHG has reported negative net income.
  • BHG had a negative operating cash flow in the past year.
BHG Yearly Net Income VS EBIT VS OCF VS FCFBHG Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2018 2019 2020 2021 2022 0 -500M -1B

1.2 Ratios

  • BHG's Return On Assets of -79.71% is on the low side compared to the rest of the industry. BHG is outperformed by 90.43% of its industry peers.
Industry RankSector Rank
ROA -79.71%
ROE N/A
ROIC N/A
ROA(3y)-26.23%
ROA(5y)N/A
ROE(3y)-110.76%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
BHG Yearly ROA, ROE, ROICBHG Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2018 2019 2020 2021 2022 -50 -100 -150 -200

1.3 Margins

  • The Profit Margin and Operating Margin and Gross Margin are not available for BHG so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
BHG Yearly Profit, Operating, Gross MarginsBHG Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2018 2019 2020 2021 2022 -20 -40 -60

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

1

2. BHG Health Analysis

2.1 Basic Checks

  • BHG does not have a ROIC to compare to the WACC, probably because it is not profitable.
  • BHG has about the same amout of shares outstanding than it did 1 year ago.
  • The debt/assets ratio for BHG is higher compared to a year ago.
BHG Yearly Shares OutstandingBHG Yearly Shares OutstandingYearly Shares Outstanding 2019 2020 2021 2022 2M 4M 6M
BHG Yearly Total Debt VS Total AssetsBHG Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2019 2020 2021 2022 1B 2B 3B 4B

2.2 Solvency

  • Based on the Altman-Z score of -1.98, we must say that BHG is in the distress zone and has some risk of bankruptcy.
  • BHG has a Altman-Z score of -1.98. This is amonst the worse of the industry: BHG underperforms 81.74% of its industry peers.
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Altman-Z -1.98
ROIC/WACCN/A
WACC6.5%
BHG Yearly LT Debt VS Equity VS FCFBHG Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2018 2019 2020 2021 2022 0 200M 400M 600M 800M 1B

2.3 Liquidity

  • BHG has a Current Ratio of 1.09. This is a normal value and indicates that BHG is financially healthy and should not expect problems in meeting its short term obligations.
  • The Current ratio of BHG (1.09) is worse than 66.09% of its industry peers.
  • A Quick Ratio of 1.09 indicates that BHG should not have too much problems paying its short term obligations.
  • BHG has a Quick ratio (1.09) which is comparable to the rest of the industry.
Industry RankSector Rank
Current Ratio 1.09
Quick Ratio 1.09
BHG Yearly Current Assets VS Current LiabilitesBHG Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2019 2020 2021 2022 200M 400M 600M 800M 1B

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

5

3. BHG Growth Analysis

3.1 Past

  • The Earnings Per Share has grown by an impressive 47.41% over the past year.
  • The Revenue has grown by 367.50% in the past year. This is a very strong growth!
  • The Revenue has been growing by 104.82% on average over the past years. This is a very strong growth!
EPS 1Y (TTM)47.41%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%78.68%
Revenue 1Y (TTM)367.5%
Revenue growth 3Y104.82%
Revenue growth 5YN/A
Sales Q2Q%39.3%

3.2 Future

  • Based on estimates for the next years, BHG will show a very strong growth in Earnings Per Share. The EPS will grow by 24.13% on average per year.
  • Based on estimates for the next years, BHG will show a very negative growth in Revenue. The Revenue will decrease by -15.72% on average per year.
EPS Next Y25.96%
EPS Next 2Y38.14%
EPS Next 3Y24.13%
EPS Next 5YN/A
Revenue Next Year-45.23%
Revenue Next 2Y-27.55%
Revenue Next 3Y-15.72%
Revenue Next 5YN/A

3.3 Evolution

  • The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
BHG Yearly Revenue VS EstimatesBHG Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2018 2019 2020 2021 2022 2023 2024 2025 2B 4B 6B
BHG Yearly EPS VS EstimatesBHG Yearly EPS VS EstimatesYearly EPS VS Estimates 2021 2022 2023 2024 2025 -50 -100

More info and screens

Find the best growth stocksShow best growing peers

1

4. BHG Valuation Analysis

4.1 Price/Earnings Ratio

  • The Price/Earnings Ratio is negative for BHG. In the last year negative earnings were reported.
  • Also next year BHG is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
BHG Price Earnings VS Forward Price EarningsBHG Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 20 30 40

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
BHG Per share dataBHG EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 200 -200

4.3 Compensation for Growth

  • A more expensive valuation may be justified as BHG's earnings are expected to grow with 24.13% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y38.14%
EPS Next 3Y24.13%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. BHG Dividend Analysis

5.1 Amount

  • BHG does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

Find the best dividend stocksShow peers with best dividend

BHG Fundamentals: All Metrics, Ratios and Statistics

BRIGHT HEALTH GROUP INC

NYSE:BHG (1/26/2024, 8:04:13 PM)

16.35

+1.4 (+9.36%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Providers & Services
Earnings (Last)11-07
Earnings (Next)03-01
Inst Owners65.17%
Inst Owner Change-97.85%
Ins Owners1738.12%
Ins Owner Change0%
Market Cap130.47M
Revenue(TTM)2.76B
Net Income(TTM)-1.64B
Analysts49.09
Price Target27.2 (66.36%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-33.04%
Min EPS beat(2)-93.71%
Max EPS beat(2)27.63%
EPS beat(4)2
Avg EPS beat(4)-29.92%
Min EPS beat(4)-93.71%
Max EPS beat(4)33.99%
EPS beat(8)2
Avg EPS beat(8)-51.14%
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)0
Avg Revenue beat(2)-33.49%
Min Revenue beat(2)-60.77%
Max Revenue beat(2)-6.22%
Revenue beat(4)1
Avg Revenue beat(4)-30.07%
Min Revenue beat(4)-61.47%
Max Revenue beat(4)8.17%
Revenue beat(8)1
Avg Revenue beat(8)-79.17%
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)-29.82%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-20.06%
EPS NY rev (1m)0%
EPS NY rev (3m)-293.09%
Revenue NQ rev (1m)-1.13%
Revenue NQ rev (3m)0.14%
Revenue NY rev (1m)13.29%
Revenue NY rev (3m)-0.38%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 0.05
P/FCF N/A
P/OCF N/A
P/B N/A
P/tB N/A
EV/EBITDA N/A
EPS(TTM)-54.11
EYN/A
EPS(NY)-11.81
Fwd EYN/A
FCF(TTM)-285.84
FCFYN/A
OCF(TTM)-284.79
OCFYN/A
SpS345.44
BVpS-16.62
TBVpS-28.67
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -79.71%
ROE N/A
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)-26.23%
ROA(5y)N/A
ROE(3y)-110.76%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score3
Asset Turnover1.34
Health
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 27.54%
Cap/Sales 0.3%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 1.09
Quick Ratio 1.09
Altman-Z -1.98
F-Score3
WACC6.5%
ROIC/WACCN/A
Cap/Depr(3y)72.7%
Cap/Depr(5y)72.16%
Cap/Sales(3y)1.47%
Cap/Sales(5y)1.05%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)47.41%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%78.68%
EPS Next Y25.96%
EPS Next 2Y38.14%
EPS Next 3Y24.13%
EPS Next 5YN/A
Revenue 1Y (TTM)367.5%
Revenue growth 3Y104.82%
Revenue growth 5YN/A
Sales Q2Q%39.3%
Revenue Next Year-45.23%
Revenue Next 2Y-27.55%
Revenue Next 3Y-15.72%
Revenue Next 5YN/A
EBIT growth 1Y-91.36%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year100.46%
EBIT Next 3Y26.39%
EBIT Next 5YN/A
FCF growth 1Y-1745.74%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-1480.68%
OCF growth 3YN/A
OCF growth 5YN/A

BRIGHT HEALTH GROUP INC / BHG Fundamental Analysis FAQ

What is the ChartMill fundamental rating of BRIGHT HEALTH GROUP INC (BHG) stock?

ChartMill assigns a fundamental rating of 2 / 10 to BHG.


What is the valuation status of BRIGHT HEALTH GROUP INC (BHG) stock?

ChartMill assigns a valuation rating of 1 / 10 to BRIGHT HEALTH GROUP INC (BHG). This can be considered as Overvalued.


What is the profitability of BHG stock?

BRIGHT HEALTH GROUP INC (BHG) has a profitability rating of 0 / 10.


Can you provide the expected EPS growth for BHG stock?

The Earnings per Share (EPS) of BRIGHT HEALTH GROUP INC (BHG) is expected to grow by 25.96% in the next year.